3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one

C16H32N2O — CID 83246568

IUPAC3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
SMILESCCC(C)C(C)N1C(=O)C(CC(C)C)NC1C(C)C
InChIInChI=1S/C16H32N2O/c1-8-12(6)13(7)18-15(11(4)5)17-14(16(18)19)9-10(2)3/h10-15,17H,8-9H2,1-7H3
InChIKeyWASIFOQVYRGWMT-UHFFFAOYSA-N
MW268.44 g/mol
LogP3.25
Rot. Bonds6

About 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one

3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one (PubChem CID 83246568) has the molecular formula C16H32N2O and a molecular weight of 268.44 g/mol. Its IUPAC name is 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one.

Molecular Properties

Compound Name3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
PubChem CID83246568
Molecular FormulaC16H32N2O
Molecular Weight268.44 g/mol
Exact Mass268.25
IUPAC Name3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
SMILESCCC(C)C(C)N1C(=O)C(CC(C)C)NC1C(C)C
InChIInChI=1S/C16H32N2O/c1-8-12(6)13(7)18-15(11(4)5)17-14(16(18)19)9-10(2)3/h10-15,17H,8-9H2,1-7H3
InChIKeyWASIFOQVYRGWMT-UHFFFAOYSA-N
XLogP3.25
TPSA32.34 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds6
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500268.44
LogP ≤ 53.25
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Analyze 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(1-cyclopropylbutan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
CID 83263401
5-ethyl-3-(3-methylpentan-2-yl)-2-(2-methylpropyl)imidazolidin-4-one
CID 83246049
3-[(2-methylcyclopropyl)methyl]-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
CID 113464309
3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
CID 83243563
5-butyl-2-methyl-3-(3-methylpentan-2-yl)imidazolidin-4-one
CID 83246045
3-(2-methylpentan-3-yl)-5-(2-methylpropyl)-2-propylimidazolidin-4-one
CID 83247146
3-(1-ethoxypropan-2-yl)-2-methyl-5-(2-methylpropyl)imidazolidin-4-one
CID 83246403
5-(2-methylpropyl)-3-(2-methylsulfinylethyl)-2-propan-2-ylimidazolidin-4-one
CID 113480746
3-[(2-methylcyclopentyl)methyl]-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
CID 107421415
5-benzyl-3-butan-2-yl-2-propan-2-ylimidazolidin-4-one
CID 83239760
5-butyl-3-(1-methoxypropan-2-yl)-2-propan-2-ylimidazolidin-4-one
CID 83239379
3-(1-cyclopropylethyl)-2-propan-2-yl-5-propylimidazolidin-4-one
CID 83243853

Frequently Asked Questions

What is the IUPAC name of 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
The IUPAC name of 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one (CID 83246568) is 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one.
What is the SMILES notation for 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
The canonical SMILES for 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one is CCC(C)C(C)N1C(=O)C(CC(C)C)NC1C(C)C.
What is the InChIKey of 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
The InChIKey is WASIFOQVYRGWMT-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H32N2O/c1-8-12(6)13(7)18-15(11(4)5)17-14(16(18)19)9-10(2)3/h10-15,17H,8-9H2,1-7H3.
What are the key properties of 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one has a molecular weight of 268.44 g/mol, XLogP of 3.25, 6 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3-methylpentan-2-yl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one is sourced from PubChem (CID 83246568), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).